Clinical and Translational Gastroenterology




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

Many Paradoxes of My Gastroenterology Practice

Sonnenberg, Amnon MD, MSc1,2

doi : 10.14309/ctg.0000000000000328

April 2021 - Volume 12 - Issue 4 - p e00328

A paradox describes the clash between 2 seemingly reasonable prepositions whose joint occurrence appears impossible. Like any other human endeavor, medicine is also filled with paradoxes that await resolution. This editorial lists several common paradoxes frequently encountered by clinical gastroenterologists. These examples illustrate the interplay between risk and benefit, cost and effect, disease and cure, and escape and exposure. It is hoped that addressing these paradoxes and trying to resolve their underlying contradictions will ultimately lead to a more efficacious and rational delivery of healthcare.

Buy The Package and View The Article Online


A Multicenter, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Saroglitazar in Patients With Primary Biliary Cholangitis

Vuppalanchi, Raj MD1; González-Huezo, Ma Saraí MD2; Payan-Olivas, Ramon MD3; Muñoz-Espinosa, Linda E. MD, PhD4; Shaikh, Farheen BUMS5; Pio Cruz-Lopez, Jose L. MD6; Parmar, Deven MD5

doi : 10.14309/ctg.0000000000000327

April 2021 - Volume 12 - Issue 4 - p e00327

Patients with primary biliary cholangitis (PBC) without biochemical response to ursodeoxycholic acid (UDCA) are at increased risk of liver-related mortality. Saroglitazar is a novel peroxisome proliferator-activated receptor (PPAR) agonist with dual PPAR agonistic properties (?/?). There is a strong mechanistic rationale for studying saroglitazar in PBC because PPAR? is a molecular target of fibrates that showed improvements in liver tests in patients with PBC.

Buy The Package and View The Article Online


Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk—A Single-Center Cross-Sectional Study

Semmler, Georg MD1; Wernly, Sarah MD1; Bachmayer, Sebastian MD1; Wernly, Bernhard MD, PhD2; Schwenoha, Lena1; Huber-Schönauer, Ursula Dr Mag1; Stickel, Felix MD3; Niederseer, David MD, PhD4; Aigner, Elmar MD5; Datz, Christian MD1

doi : 10.14309/ctg.0000000000000326

April 2021 - Volume 12 - Issue 4 - p e00326

Although a milder metabolic phenotype of nonalcoholic fatty liver disease (NAFLD) in lean patients (body mass index [BMI] <25 kg/m2) compared to overweight/obese patients with NAFLD is assumed, the relevance of NAFLD among lean subjects remains a matter of debate. We aimed to characterize the metabolic/cardiovascular phenotype of lean patients with NAFLD.

Buy The Package and View The Article Online


Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease Using Noninvasive Tests From Primary Care and Endocrinology Real-World Practices

Younossi, Zobair M. MD, MPH1,2; Pham, Huong BS1; Felix, Sean BS1; Stepanova, Maria PhD3; Jeffers, Thomas BS1,4; Younossi, Elena BS1; Allawi, Hussain MD1; Lam, Brian PA-C1,4; Cable, Rebecca BS1,4; Afendy, Mariam BS1,4; Younoszai, Zahra MPH1,4; Afendy, Arian BS1,4; Rafiq, Nila MD1,2,4; Alzubaidi, Nahrain MD2,4; Ousman, Yasser MD2; Bailey, Marc MD2; Chris, Zik MD2; Castillo-Catoni, Maria MD2; Fozdar, Pratima MD2; Ramirez, Maria MD2; Husain, Mehreen MD2; Hudson, Evis MD2; Schneider, Ingrid MD1; Golabi, Pegah MD1,2; Nader, Fatema MSBM3

doi : 10.14309/ctg.0000000000000340

April 2021 - Volume 12 - Issue 4 - p e00340

We aimed to identify high-risk nonalcoholic fatty liver disease (NAFLD) patients seen at the primary care and endocrinology practices and link them to gastrohepatology care.

Buy The Package and View The Article Online


Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Qu, Ying MD1; Song, Yan-Yan PhD2; Chen, Cheng-Wei MD3; Fu, Qing-Chun MD3; Shi, Jun-Ping MD4; Xu, Yun MD5; Xie, Qing MD6; Yang, Yong-Feng MD7; Zhou, Yong-Jian MD8; Li, Liang-Ping MD9; Xu, Ming-Yi MD1; Cai, Xiao-Bo MD1; Zhang, Qi-Di MD1; Yu, Hao PhD10; Fan, Jian-Gao MD11; Lu, Lun-Gen MD1

doi : 10.14309/ctg.0000000000000323

April 2021 - Volume 12 - Issue 4 - p e00323

To evaluate the diagnostic performance of ultrasound attenuation parameter (UAP) and liver stiffness measurement (LSM) by FibroTouch for diagnosis of hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).

Buy The Package and View The Article Online


Prediction of Hepatocellular Carcinoma by Liver Stiffness Measurements Using Magnetic Resonance Elastography After Eradicating Hepatitis C Virus

Kumada, Takashi MD, PhD1; Toyoda, Hidenori MD, PhD2; Yasuda, Satoshi MD, PhD2; Sone, Yasuhiro MD, PhD3; Ogawa, Sadanobu4; Takeshima, Kenji4; Tada, Toshifumi MD, PhD5; Ito, Takanori MD, PhD6; Sumida, Yoshio MD, PhD7; Tanaka, Junko PhD8

doi : 10.14309/ctg.0000000000000337

April 2021 - Volume 12 - Issue 4 - p e00337

Liver fibrosis stage is one of the most important factors in stratifying the risk of developing hepatocellular carcinoma (HCC). We evaluated the usefulness of liver stiffness measured by magnetic resonance elastography (MRE) to stratify the risk of developing HCC in patients who underwent MRE before receiving direct-acting antivirals (DAAs) and subsequently achieved sustained virological response (SVR).

Buy The Package and View The Article Online


Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study

Wilson, Aze MD, PhD1,2,3; Wang, Qian BSc4; Choi, Yun-Hee PhD5; Ponich, Terry MD2; Gregor, James C. MD2; Chande, Nilesh MD2; Yan, Brian MD2; Sey, Michael MD2; Beaton, Melanie MD2; Kim, Richard B. MD1,3

doi : 10.14309/ctg.0000000000000332

April 2021 - Volume 12 - Issue 4 - p e00332

Azathioprine-induced pancreatitis is an idiosyncratic and unpredictable response, occurring in up to 7% of azathioprine-exposed patients with inflammatory bowel disease (IBD). The haplotype HLADQA1-HLADRB1*07:01A>C is strongly associated with azathioprine-induced pancreatitis in IBD. We aimed to evaluate whether pretreatment HLADQA1-HLADRB1*07:01A>C screening will reduce the risk of azathioprine-induced pancreatitis.

Buy The Package and View The Article Online


Increased Gene Copy Number of DEFA1A3 Is Associated With the Severity of Ulcerative Colitis

Kanmura, Shuji MD, PhD1; Morinaga, Yuko MS1; Tanaka, Akihito MD, PhD1; Komaki, Yuga MD, PhD1; Iwaya, Hiromichi MD1; Kumagai, Kotaro MD, PhD1; Mawatari, Seiichi MD, PhD1; Sasaki, Fumisato MD, PhD1; Tanoue, Shiroh MD, PhD1; Hashimoto, Shinichi MD, PhD1; Sameshima, Yoichi MD2; Ono, Yohei MD, PhD3; Ohi, Hidehisa MD, PhD3; Ido, Akio MD, PhD1

doi : 10.14309/ctg.0000000000000331

April 2021 - Volume 12 - Issue 4 - p e00331

DEFA1A3 encodes human neutrophil peptides (HNPs) 1–3 and has multiple copy number variations (CNVs). HNPs are associated with innate immunity. Ulcerative colitis (UC), a chronic inflammatory gastrointestinal disorder, is a life-threatening condition, and predictive markers of UC severity are needed. This study investigated the relationship between DEFA1A3 CNV and UC severity.

Buy The Package and View The Article Online


Ileal Crohn's Disease Exhibits Similar Transmural Fibrosis Irrespective of Phenotype

Tavares de Sousa, Helena MD1,2; Gullo, Irene MD, PhD3,4,5; Castelli, Claudia MD6; Dias, Cláudia Camila BSc, MSc, PhD7,8; Rieder, Florian MD, PhD9,10; Carneiro, Fátima MD, PhD3,4,5; Magro, Fernando MD, PhD11,12,13

doi : 10.14309/ctg.0000000000000330

April 2021 - Volume 12 - Issue 4 - p e00330

In Crohn's disease (CD), the assessment of transmural inflammation and fibrosis is of utmost importance. This study aimed to quantify these parameters in CD ileal specimens and correlate them with disease progression.

Buy The Package and View The Article Online


Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro

Lepczy?ska, Ma?gorzata MS1; Dzika, Ewa PhD1; Chen, WenChieh MD2; Lu, Chien-Yu MD3,4

doi : 10.14309/ctg.0000000000000325

April 2021 - Volume 12 - Issue 4 - p e00325

Proton pump inhibitors (PPIs) and histamine receptor 2 (H2) antagonists are commonly prescribed medications. Association between PPIs and alteration of the gut microbiota has been reported. Blastocystis, the most common intestinal protozoan worldwide, occurs in both healthy and symptomatic people with gastrointestinal or cutaneous disorders, with controversial pathogenicity. The current study was aimed to investigate the influence of PPIs and H2 blockers on the in vitro proliferation of selected intestinal bacteria, fungi, and protozoa.

Buy The Package and View The Article Online


Differential mRNA Expression in Ileal Mucosal Biopsies of Patients With Diarrhea- or Constipation-Predominant Irritable Bowel Syndrome

Wang, Xiao Jing MD1; Carlson, Paula BS1; Chedid, Victor MD1; Maselli, Daniel B. MD1; Taylor, Ann L. BA1; McKinzie, Sanna MS1; Camilleri, Michael MD1

doi : 10.14309/ctg.0000000000000329

April 2021 - Volume 12 - Issue 4 - p e00329

Previous studies in patients with irritable bowel syndrome (IBS) showed immune activation, secretion, and barrier dysfunction in duodenal, jejunal, or colorectal mucosa. This study aimed to measure ileal mucosal expression of genes and proteins associated with mucosal functions.

Buy The Package and View The Article Online


Endoscopic Resection Before Surgery Does Not Affect the Recurrence Rate in Patients With High-Risk T1 Colorectal Cancer

Takamaru, Hiroyuki MD, PhD1; Saito, Yutaka MD, PhD1; Sekiguchi, Masau MD, PhD1,2; Yamada, Masayoshi MD, PhD1; Sakamoto, Taku MD, PhD1; Matsuda, Takahisa MD, PhD1,2; Sekine, Shigeki MD, PhD3; Ochiai, Hiroki MD, PhD4; Tsukamoto, Shunsuke MD, PhD4; Shida, Dai MD, PhD4; Kanemitsu, Yukihide MD4

doi : 10.14309/ctg.0000000000000336

April 2021 - Volume 12 - Issue 4 - p e00336

Patients with high-risk T1 colorectal cancer (CRC) after endoscopic resection (ER) should undergo surgery in view of the risk of lymph node metastasis. Although additional surgery can potentially prevent recurrence, there is a paucity of data and longitudinal studies exploring this potential. Hence, this study aimed to evaluate the prolonged influence of ER before additional surgery on recurrence in T1 CRC.

Buy The Package and View The Article Online


Translating Fecobionics Into a Technique That Addresses Clinical Needs for Objective Perineal Descent Measurements

Zhuang, Z. MEng1; Hung, H.Y. MD, PhD2; Chen, S.C. MD1; Futaba, K. MD, PhD1; Gregersen, H. MD, PhD1

doi : 10.14309/ctg.0000000000000342

April 2021 - Volume 12 - Issue 4 - p e00342

Perineal descent is a phenomenon associated with anorectal dysfunction. It is diagnosed by defecography but subjected to manual measurements on the images/videos and interobserver bias. Fecobionics is a simulated feces for assessing important physiological parameters during defecation. Here, we translate Fecobionics into a new method for estimation of perineal descent based on electronic signals from the embedded inertial measurement units (IMUs).

Buy The Package and View The Article Online


Functional Dyspepsia, Peptic Ulcer, and Helicobacter pylori Infection in a Rural Community of South Asia: An Endoscopy-Assisted Household Survey

Rahman, M. Masudur FCPS, MD, FACP, FACG, FRCP1; Ghoshal, Uday C. MD, DNB, DM, FACG, RFF, FAMS, FRCP2; Kibria, Md. Golam FCPS, MD, FACG1; Sultana, Nigar FCPS3; Yusuf, M. Abdllah MPhil4; Nahar, Shamsun MSc5; Ahmed, Faruque FCPS, MD, FRCP1; Rowshon, AHM FCPS, MD6; Hasan, Mahmud FCPS, FRCP, PhD7

doi : 10.14309/ctg.0000000000000334

April 2021 - Volume 12 - Issue 4 - p e00334

Functional dyspepsia (FD), although commoner than organic dyspepsia (OD) in-hospital studies, community data, particularly from rural areas, are lacking. We performed a rural community study in Bangladesh with the primary aims to evaluate (i) the prevalence of uninvestigated dyspepsia (UD), FD, and OD and (ii) the risk factors for UD.

Buy The Package and View The Article Online


Increased Risk of Major Depressive Disorder After Cholecystectomy: A Nationwide Population-Based Cohort Study in Korea

Jin, Eun Hyo MD, PhD1; Han, Kyungdo PhD2; Lee, Dong Ho MD, PhD3; Shin, Cheol Min MD, PhD3; Lim, Joo Hyun MD, PhD1; Yoon, Hyuk MD, PhD3; Kim, Nayoung MD, PhD3

doi : 10.14309/ctg.0000000000000339

April 2021 - Volume 12 - Issue 4 - p e00339

This study investigated the risk of depression in Korean adults who underwent cholecystectomy and appeared for subsequent long-term follow-ups. A national population-based data set was used for analysis.

Buy The Package and View The Article Online


Prevalence and Persistent Shedding of Fecal SARS-CoV-2 RNA in Patients With COVID-19 Infection: A Systematic Review and Meta-analysis

Zhang, Yawen MD, PhD1; Cen, Mengsha MM1; Hu, Mengjia MM2; Du, Lijun MD, PhD1; Hu, Weiling MD, PhD1; Kim, John J. MD, MS3; Dai, Ning MD, PhD1,4

doi : 10.14309/ctg.0000000000000343

April 2021 - Volume 12 - Issue 4 - p e00343

The prevalence and shedding of fecal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA indicate coronavirus disease 2019 (COVID-19) infection in the gastrointestinal (GI) tract and likely infectivity. We performed a systemic review and meta-analysis to evaluate the prevalence and the duration of shedding of fecal RNA in patients with COVID-19 infection.

Buy The Package and View The Article Online


Oral Proton Pump Inhibitors May Be as Effective as Intravenous in Peptic Ulcer Bleeding: A Systematic Review and Meta-analysis

Csiki, Endre MD1,2; Szabó, Hanna MD1,3; Hanák, Lilla MSc1; Szakács, Zsolt MD1; Kiss, Szabolcs MD1,4; Vörhendi, Nóra MD1; Pécsi, Dániel MD, PhD5; Hegyi, Eszter MD, PhD1; Hegyi, Péter MD, PhD, DSc1; Er?ss, Bálint MD, PhD1

doi : 10.14309/ctg.0000000000000341

April 2021 - Volume 12 - Issue 4 - p e00341

Current guidelines recommend intravenous (IV) proton pump inhibitor (PPI) therapy in peptic ulcer bleeding (PUB). We aimed to compare the efficacy of oral and IV administration of PPIs in PUB.

Buy The Package and View The Article Online


Reviewer Recognition 2020

doi : 10.14309/ctg.0000000000000352

April 2021 - Volume 12 - Issue 4 - p e00352

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?